The Regulation of Stem Cell Products

来源 :2013 Annual Meeting of the Asia Pacific Chapter of the Tissu | 被引量 : 0次 | 上传用户:kaiserking
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Stem Cells intended for use in humans are regulated under the U.S.Food and Drug Administrations regulations governing human cells, tissues, cellular and tissue based products (HCT/Ps).
其他文献
We have examinedthe epidermal growth factor receptor (EGFR)-sensitive motility signal proteins of amniotic epithelial (FL) ceils responding to a 0.4mT power frequency magnetic field (PFMF) exposure fo
Our previous studies have indicated that exposure CHL and FL cellstoa 0.4mT 50HzPFMF for 30 min induced EGFR clustering in cell surfaces and among purified EGFR proteins, whichwere inhibited by the ty
Background: Microwave exposure has multipleadverse effects on the nervous system resulting in various cognitive and behavioral deficits.However the underlying molecular mechanism remains largely unkno
Background: The ultra-wideband (UWB) microwave imaging is a promising method of detecting the breast cancer.The confocal imaging technique in this application faces the problem of dispersion propertie
Background: Blue light receptor cryptochrome was suggested to be magnetoreceptor, which was firstly found in Arabidopsis and activated by blue light.Then, cryptochrome was confirmed to be involved in
Background: Many evidences have indicated that microwave radiation is a threat to human health, and there is a growing public concern about its protection.In this studywe have investigated the damagee
Background: With rapid development of industrialization, informatization and urbanization in China, the electromagnetic environment is increasingly complex, and electromagnetic interference is increas
Therapeutic goods are regulated in Australia by the Therapeutic Goods Administration (TGA), a Division of the Federal Governments Department of Health & Ageing.
会议
The regulatory environment for cell-and tissue-based therapeutic (CTT) products is rapidly evolving and drug regulatory agencies are working towards establishing a risk-based system in the regulation
会议
With the growing number of tissue engineering and regenerative medicine projects in Asia, the demand of GMP facilities for production of cell banks or/and manufacture of tissue engineering and regener
会议